Literature DB >> 30825046

Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study.

Peijin Han1, Aurelian Bidulescu2, John R Barber1, Steven H Zeisel3, Corinne E Joshu1,4, Anna E Prizment5, Mara Z Vitolins6, Elizabeth A Platz7,8,9,10.   

Abstract

PURPOSE: Two prior cohort studies suggested that choline, but not betaine intake, is associated with an increased risk of advanced prostate cancer (PCa). Given that evidence remains limited, we evaluated whether intakes of choline and derivative betaine are associated with total and lethal PCa risk and PCa death in men with PCa.
METHODS: We included 6,528 men (24.4% African American) without a cancer diagnosis at baseline (1987-1989) followed through 2012. Dietary intake was assessed using a food frequency questionnaire coupled with a nutrient database. We used Cox proportional hazards regression to estimate hazards ratios (HRs) and 95% confidence intervals (CIs) of total and lethal PCa risk overall and by race.
RESULTS: Choline intake was not associated with total (n = 811) or lethal (n = 95) PCa risk overall or by race. Betaine intake was inversely associated with lethal (tertile 3 vs 1, HR 0.59, 95% CI 0.35-1.00, p trend = 0.04), but not total PCa risk; patterns for lethal PCa were similar by race. Neither nutrient was associated with PCa death in men with PCa.
CONCLUSIONS: Choline intake was not associated with total or lethal PCa or with PCa death in men with PCa. Betaine intake was inversely associated with lethal, but not total PCa risk or with PCa death in men with PCa. Our results do not support the hypothesis that higher choline intake increases lethal PCa risk, but do suggest that higher betaine intake may be associated with lower lethal PCa risk. Further investigation with a larger number of lethal cases is needed.

Entities:  

Keywords:  Case-fatality; Choline; Incidence; Lethal prostate cancer; Race

Mesh:

Substances:

Year:  2019        PMID: 30825046      PMCID: PMC6553878          DOI: 10.1007/s10552-019-01148-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  22 in total

1.  Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment.

Authors:  K R Keshari; H Tsachres; R Iman; L Delos Santos; Z L Tabatabai; K Shinohara; D B Vigneron; J Kurhanewicz
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

2.  Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline.

Authors:  Mihai D Niculescu; Steven H Zeisel
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

3.  Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.

Authors:  Sebastian A Müller; Korbinian Holzapfel; Christof Seidl; Uwe Treiber; Bernd J Krause; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-08       Impact factor: 9.236

4.  One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.

Authors:  Mattias Johansson; Bethany Van Guelpen; Stein Emil Vollset; Johan Hultdin; Anders Bergh; Tim Key; Oivind Midttun; Göran Hallmans; Per M Ueland; Pär Stattin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

5.  Choline intake and risk of lethal prostate cancer: incidence and survival.

Authors:  Erin L Richman; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci; Steven H Zeisel; Walter C Willett; June M Chan
Journal:  Am J Clin Nutr       Date:  2012-09-05       Impact factor: 7.045

6.  Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Authors:  Karen Balassiano; Sheila Lima; Mazda Jenab; Kim Overvad; Anne Tjonneland; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Federico Canzian; Rudolf Kaaks; Heiner Boeing; Karina Meidtner; Antonia Trichopoulou; Pagona Laglou; Paolo Vineis; Salvatore Panico; Domenico Palli; Sara Grioni; Rosario Tumino; Eiliv Lund; H Bas Bueno-de-Mesquita; Mattjis E Numans; Petra H M Peeters; J Ramon Quirós; María-José Sánchez; Carmen Navarro; Eva Ardanaz; Miren Dorronsoro; Göran Hallmans; Roger Stenling; Roy Ehrnström; Sara Regner; Naomi E Allen; Ruth C Travis; Kay-Tee Khaw; G Johan A Offerhaus; Nuria Sala; Elio Riboli; Pierre Hainaut; Jean-Yves Scoazec; Bakary S Sylla; Carlos A Gonzalez; Zdenko Herceg
Journal:  Cancer Lett       Date:  2011-07-14       Impact factor: 8.679

Review 7.  DNA methylation, cancer susceptibility, and nutrient interactions.

Authors:  Cindy D Davis; Eric O Uthus
Journal:  Exp Biol Med (Maywood)       Date:  2004-11

8.  Television, physical activity, diet, and body weight status: the ARIC cohort.

Authors:  Anne-Marie Meyer; Kelly R Evenson; David J Couper; June Stevens; Mark A Pereria; Gerardo Heiss
Journal:  Int J Behav Nutr Phys Act       Date:  2008-12-17       Impact factor: 6.457

9.  Repeatability and measurement error in the assessment of choline and betaine dietary intake: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Aurelian Bidulescu; Lloyd E Chambless; Anna Maria Siega-Riz; Steven H Zeisel; Gerardo Heiss
Journal:  Nutr J       Date:  2009-02-20       Impact factor: 3.271

10.  Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Aurelian Bidulescu; Lloyd E Chambless; Anna Maria Siega-Riz; Steven H Zeisel; Gerardo Heiss
Journal:  BMC Cardiovasc Disord       Date:  2007-07-13       Impact factor: 2.298

View more
  4 in total

1.  Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance.

Authors:  Jiliang Xia; Jingyu Zhang; Xuan Wu; Wanqing Du; Yinghong Zhu; Xing Liu; Zhenhao Liu; Bin Meng; Jiaojiao Guo; Qin Yang; Yihui Wang; Qinglin Wang; Xiangling Feng; Guoxiang Xie; Yi Shen; Yanjuan He; Juanjuan Xiang; Minghua Wu; Gang An; Lugui Qiu; Wei Jia; Wen Zhou
Journal:  Nat Commun       Date:  2022-07-11       Impact factor: 17.694

2.  Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort.

Authors:  Chad A Reichard; Bryan D Naelitz; Zeneng Wang; Xun Jia; Jianbo Li; Meir J Stampfer; Eric A Klein; Stanley L Hazen; Nima Sharifi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-28       Impact factor: 4.090

3.  Association between dietary choline and betaine intake and 10.6-year cardiovascular disease in adults.

Authors:  Mahdieh Golzarand; Parvin Mirmiran; Fereidoun Azizi
Journal:  Nutr J       Date:  2022-01-05       Impact factor: 3.271

4.  A biochemical comparison of the lung, colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy.

Authors:  Cong Hu; Zhigang Liu; Hailin Zhao; Lingzhi Wu; Qingquan Lian; Daqing Ma; Jia V Li
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.